Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement

Back

ESC Professional Premium Access

Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement

Session: New insights around surgical valve replacement

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor I. Fialho (Lisbon, PT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Ines Fialho

Hospital Fernando Fonseca, Lisbon (Portugal)

4 presentations

0 follower

6 more presentations in this session

Biological versus mechanical SAVR patient's age threshold: PARTNER II study influenced real world practice in a large French cohort.

Speaker: Doctor Y. Chabry (Paris, FR)

Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis

Speaker: Professor T. Modine (Bordeaux, FR) Professor N. van Mieghem (Rotterdam, NL)

Early mitral valve repair surgery versus active surveillance in patients with asymptomatic severe primary mitral regurgitation; insights from the Dutch AMR registry

Speaker: Doctor S. El Mathari (Amsterdam, NL)

Elderly patients with severe aortic stenosis - does moderate mitral regurgitation require simultaneous surgical intervention?

Speaker: Doctor A. Kwiecien (Zabrze, PL)

Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation

Speaker: Doctor S. Kazum (Petah Tikva, IL)

Access the full session

New insights around surgical valve replacement

Speakers: Doctor I. Fialho, Doctor Y. Chabry, Professor T. Modine, Professor N. van Mieghem, Doctor S. El Mathari...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement

About the speaker

Doctor Ines Fialho

6 more presentations in this session

Biological versus mechanical SAVR patient's age threshold: PARTNER II study influenced real world practice in a large French cohort.

Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis

Early mitral valve repair surgery versus active surveillance in patients with asymptomatic severe primary mitral regurgitation; insights from the Dutch AMR registry

Elderly patients with severe aortic stenosis - does moderate mitral regurgitation require simultaneous surgical intervention?

Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation

Access the full session

New insights around surgical valve replacement

About the event

ESC Congress 2023

ESC 365 is supported by